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Abstract
Background: Collaborative care involves active engagement of primary care and hospital physicians in shared care
of patients beyond usual discharge summaries. This enhances community-based care and reduces dependence on
specialists and hospitals. The model, successfully implemented in chronic care management, may have utility for
treatment of depression in cancer. The aim of this systematic review was to identify components, delivery and roles
and responsibilities within collaborative interventions for depression in the context of cancer.
Methods: Medline, PsycINFO, CINAHL, Embase, Cochrane Library and Central Register for Controlled Trials databases
were searched to identify studies of randomised controlled trials comparing a treatment intervention that met the
definition of collaborative model of depression care with usual care or other control condition. Studies of adult cancer
patients with major depression or a non-bipolar depressive disorder published in English between 2005 and January
2018 were included. Cochrane checklist for risk of bias was completed (Study Prospero registration: CRD42018086515).
Results: Of 8 studies identified, none adhered to the definition of ‘collaborative care’. Interventions delivered were
multi-disciplinary, with care co-ordinated by nurses (n = 5) or social workers (n = 2) under the direction of psychiatrists
(n = 7). Care was primarily delivered in cancer centres (n = 5). Care co-ordinators advised primary care physicians (GPs)
of medication changes (n = 3) but few studies (n = 2) actively involved GPs in medication prescribing and
management.
Conclusions: This review highlighted joint participation of GPs and specialist care physicians in collaborative care
depression management is promoted but not achieved in cancer care. Current models reflect hospital-based
multi-disciplinary models of care.
Protocol registration: The protocol for this systematic review has been registered with PROSPERO. The
registration number is CRD42018086515.
Keywords: Collaborative care, Shared care, Systematic review, Depression, Cancer, Randomised controlled trial
Background
A diagnosis of cancer impacts individuals’ psychological
and physical wellbeing. Prevalence estimates of major
depression (16%), minor depression and dysthymia
(22%) in cancer patients are higher than in the general
population. [1, 2] In palliative settings, the prevalence of
depression approaches 49%. [3] Inadequate treatment of
depression results in poorer adherence to anti-cancer
treatments, decreased tolerance of cancer treatment
side-effects, higher use of health care resources including
increased hospital re-admissions, may adversely impact on
interpersonal relationships and reduced overall survival.
[3–9] Co-existing depression therefore poses a significant
burden for patients, families and the health system. Cogni-
tive behavioural therapy (CBT) is effective in treating
depression [10] with a meta-analysis (n = 198 studies, 22,
238 patients) reporting medium to large effect sizes
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sustained 6–12months post intervention. A recent
meta-analysis also confirmed the effectiveness of anti-
depressant medication in the treatment of depression [11]
both in combination with psychological therapy and as
primary treatment. [12] To guide evidence-based treat-
ment, there has been a renewed effort to promote routine
distress screening as a first step to improve detection and
hence treatment for depression in cancer care. [13] Such
strategies have included the development of a clinical
pathway for identification and management of depression
in adults with cancer, an international first. [14]
Despite increased evidence about effective treatments,
many patients still do not seek treatment for their
depression. For instance, a meta-analysis of 53 studies
(n = 12,052) found in a research context less than 60% of
distressed cancer patients engage in psychological treat-
ment. [15] Uptake in routine care is even lower. [16] At
a system level access to treatment is constrained by a
shortfall in the psycho-oncology workforce resulting in
long waiting lists and geographical disparities in access.
[17–19] Practical constraints such as transport, incon-
venience and cost have also been suggested. [20, 21]
Normalisation of distress and attribution of somatic
depression symptoms to cancer by clinicians also means
depression goes untreated and patients’ attitudes to
mental illness are also likely to play a role. [22] Patient
factors such as negative attitudes to mental health and
stigma also reduce patient willingness to access treat-
ment. [23]. To address perceived barriers, models of care
that encompass systematic identification of depression
in cancer patients, reduce dependence on specialist
input and enable timely access to evidence-based treat-
ment have been proposed.
The collaborative care model, based on the principles
of chronic disease management, has been successfully
implemented to treat medical conditions including de-
pression. [24, 25] Core components of collaborative care
for depression are: i) a multi-professional approach to
patient care, ii) a structured management plan tailored
to depression symptom severity, iii) scheduled patient
follow-ups and iv) enhanced inter-professional commu-
nication. [26] The model endorses a multi-disciplinary
approach involving joint participation of primary and
specialist care physicians in planned delivery of care over
and above routine discharge and referral. [23] A key
aspect of effective collaborative care is case management
[27] in which a member of the clinical team works
closely with the main treating physician and monitors
patient progress including adherence to psychological
and pharmacological treatments, initiating treatment
changes as necessary. [28] A meta-analysis of collabora-
tive care interventions (n = 37 studies, 12,355 patients
with depression receiving primary care) found that inter-
ventions that included a mental health professional as a
care provider within the clinical team reported the lar-
gest effect sizes. [29]
The evidence base for collaborative care for depression
among patients with cancer is rapidly developing. A
recent meta-analysis of studies (n = 8) purporting to be
collaborative care interventions concluded that the inter-
ventions were significantly more effective than usual
care (standardized mean difference = − 0.49, p = 0.003),
with remission rates for depression higher in the inter-
vention groups at 12months. While promising, the collab-
orative care interventions identified in that meta-analysis
varied in content, intensity, and number of components,
thus making it difficult to determine the relative contribu-
tion of each component to overall effectiveness. [30] Prior
to wider implementation of the model, greater understand-
ing of the determinants essential to model success for the
treatment of depression in oncology is required. The aim
of this systematic review was to determine the fidelity of
the depression collaborative care models trialled in oncol-
ogy to the recommended collaborative care criteria. Specif-
ically, the review sought to identify reported intervention




Studies presenting primary data from randomised
controlled trials (RCTs) of adult cancer patients with major
depression or a non-bipolar depressive disorder, which
compared a treatment intervention designated as a collab-
orative (or shared) model of depression care with usual care
or other control group and published in English were in-
cluded. Non-randomised, single-arm, case control studies,
qualitative studies and case-series reports were excluded.
Participants
Studies were eligible if participants were over 18 years of
age with a current or prior diagnosis of cancer (excluding
basal cell carcinoma and squamous cell carcinoma) and
where the study population met a threshold for clinical
depression on a validated depression measure or structured
clinical interview. Studies including separate sub-group
analyses of patients that met the criteria for clinical depres-
sion were also eligible for inclusion.
Interventions
Collaborative care, defined as a treatment approach inte-
grating primary- and tertiary-level (hospital) care in the
management of co-morbid depression in cancer patients.
Controls
Treatment as usual, wait-list control groups, and other
treatment interventions.
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Outcomes
Studies reporting data on the efficacy of collaborative
care interventions.
Search strategy
Medline, PsycINFO, CINAHL, Embase and the Cochrane
Library and Central Register for Controlled Trials data-
bases were searched using the keywords and MeSH terms
[Depression/depressive disorder/ or depressive disorder,
major/or dysthymic disorder/] and [Cancer or Carcinoma
or Neoplasm] and [Collaborative Care or Shared Care or
Integrative Care] and randomised controlled trials for
English language articles published between January 2005
to January 2018 as the first collaborative care intervention
for depression in cancer was published in 2005. Primary
studies presenting data from RCTs of adult cancer patients
with major depression or a non-bipolar depressive disorder
that compared care delivered in a collaborative care model
were identified. See Additional file 1: Table S1 for an ex-
ample database search strategy. Reference lists of retrieved
articles and previous systematic reviews were also searched
for relevant publications. Searches were conducted for out-
come data for published study protocols identified.
Data abstraction
Abstracts were identified and independently reviewed by
two reviewers (SS and LV). Data extraction was independ-
ently conducted by three reviewers (SS, LV and JS) and
coding disagreements arising were discussed and consensus
coding applied. A coding framework was developed to
extract the components of collaborative care based on the
key criteria defining collaborative care models: i) multi-pro-
fessional patient care, ii) a structured stepped care manage-
ment plan, iii) scheduled patient follow-ups and iv)
enhanced inter-professional communication [23] Specific-
ally, the following information was extracted for each study:
study characteristics, including study aim(s), population,
design and primary outcome(s); intervention description,
follow up protocols and role of health professionals.
Reasons for study exclusion are listed in Additional file 2:
Table S2. The review methodology undertaken adhered to
PRISMA guidelines for systematic reviews [31] and the
search process is summarised in Fig. 1. Risk of bias was de-




Eight primary studies met the review inclusion criteria.
Mean sample size was 281 patients (SD 161.04; range
55–500). Cancer populations included lung (n = 1) [33],
upper gastrointestinal/liver (n = 1) [34], mixed breast and
gynaecological (n = 2) [34, 35] or heterogeneous (n = 4)
[36–39]. Participants had major depressive disorder (MDD)
(n = 3) [33, 36, 40], MDD or dysthymia (n = 2) [37, 38],
MDD, dysthymia or persistent depressive symptoms > 1
month (n = 1) [35] and depressive symptoms based on
self-report questionnaires only (n = 2) [34, 39] Greater
than 60% female participation was reported in six studies
[33, 35–37, 39, 40] primarily due to an over-representation
of breast cancer patients. Of the included studies three
were conducted by a single group in Scotland [31, 34, 35]
and the remainder were conducted by separate groups in
the USA. Study Characteristics are listed in Table 1.
Collaborative care interventions
Study setting
In contrast to depression collaborative care models more
broadly, five studies delivered the intervention within the
cancer centre, [34–37, 39] with a single study conducted
in primary care. [38] A further study allowed patients to
choose either the cancer centre or primary care for treat-
ment[36]and another study in advanced cancer provided
an option for care to be delivered in the patient’s home.
[40] For two studies conducted in cancer clinics much of
the care was provided via telephone/ web-based as well as
face to face blended models. [34, 39] See Table 1 for study
setting.
Model components
Classification of studies based on collaborative care inter-
ventions found three studies [33, 40] (collectively called
the SMART studies) utilised variations of a Depression
Care for People with Cancer (DCPC) intervention. [41]
Two studies [35, 38] implemented the Improving Mood –
Promoting Access to Collaborative Treatment program
(IMPACT), a stepped care management program devel-
oped for treatment of depression in older primary care pa-
tients and a third study (ADAPT-C [42]) adapted the
IMPACT protocol to incorporate a greater patient naviga-
tion role for Latino cancer patients. [37] A further two
studies reported study-specific blended face to face and
telephone [39] or web-based [34] collaborative care inter-
ventions. The key components of each intervention are
listed in Table 2.
All interventions provided psychoeducation and the
majority (n = 7) included psychological therapy and/or
anti-depressant medication. For the studies based on the
IMPACT intervention, patient preference influenced
delivery of first line psychological or anti-depressant ther-
apy. [35, 37, 38] The SMART studies [33, 36, 40] recom-
mended both psychological therapy and anti-depressant
medication, if indicated. Similarly, treatment associated
with the web-based collaborative care model was based on
patient preference for cognitive behavioural therapy (CBT),
antidepressant medication or both [34] and medication
alone was considered first line treatment in the Kroenke
trial. [39] In those studies where psychological treatment
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was a component of the intervention, treatment length
ranged from 8 weekly sessions [33] up to 10 sessions over
3–4months [31, 34, 35] with Problem Solving Treatment
(PST) and Behavioural Activation the most common
psychological interventions. [33, 35–38, 40] A single study
characterised their therapy as CBT. [34] One study did not
include a psychological therapy option as part of the treat-
ment plan. [39] Six studies reported data on psychological
treatments received. [33, 35, 36, 39, 40] Rate of uptake for
psychological treatment in the intervention groups were
higher than control groups and ranged from 5 to
98%. [33, 35–37, 40] Studies reliant on patient prefer-
ences for either psychological or pharmacological depres-
sion treatment reported lower rates of uptake (5–43%).
[35, 37] Similarly, rates of antidepressant use were higher
than controls and ranged from 35 to 85% of participants
at 6months. [33, 36, 37, 39, 40]
Five studies included training in intervention delivery
for care co-ordinators [33, 34, 36, 37, 40] and a single
study documented training for oncologists responsible
for antidepressant management. [35] Care co-ordinators’
fidelity to the intervention manual was formally assessed
in four studies [33, 36, 37, 40] although fidelity assess-
ment and ongoing education were not included as part
of the protocol for studies where the role of prescribing
was delegated to oncologists and GPs.
Inter-professional roles within the collaborative care model
With respect to multi-professional involvement, all studies
included a care co-ordinator and a mental health specialist
as the primary members of the care team. Across studies,
delivery of the psychological/psychoeducation components
of the intervention as well as patient liaison and assess-
ment of treatment adherence was undertaken by an appro-
priately trained nurse (n = 4), [33, 36, 39, 40] social worker
(n = 2) [35, 37] or a psychologist (n = 1) [34] with one
study including both a nurse and a psychologist. [38] The
care co-ordinators all underwent formal study-specific
training and had weekly [33, 34, 36–40] or bi-weekly [35]
supervision to review patient progress and initiate treat-
ment adjustments, as required. Supervision was generally
provided by a psychiatrist (n = 7), although in one study a
clinical psychologist was the appointed supervisor. [32]
Fig. 1 (PRISMA diagram): Search process for the review (as at January 2018)
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Despite being classified as collaborative care interven-
tions, studies deviated from the model in terms of wider
inter-professional involvement in treatment, with four
studies reporting oncologists were typically informed of
the patient’s diagnosis but had minimal engagement with
respect to treatment decision-making. [33, 36, 37, 40] In
one study [35] the psychiatrist provided advice to the
oncologist with respect to anti-depressant treatment ad-
justment/ follow up and in a second study, the oncolo-
gist followed evidence-based anti-depressant prescribing
and management algorithms, with little input from the
psychiatrist. [39] Similarly, three studies reported little
or no primary care (GP) involvement in treatment
decision-making and no documented contact with the
GP by the treating team. [35, 37, 39] In the studies utilis-
ing the DPCP intervention (SMART studies), [31, 34, 35]
although the GPs were responsible for anti-depressant
prescribing, clinical decisions and recommendations for
medication treatment and/or adjustment were made by
the psychiatrist, with little engagement with the GP
around treatment planning. A single study reported GP
prescribing based on evidence-based algorithms [38] and
one study divided prescribing responsibility between the
medical team and the patient’s GP, although the role of
each clinician was not clearly defined. [34] Table 3 lists
the health professional roles across studies.
A structured management plan tailored to depression
symptom severity
Consistent with the collaborative care model, all interven-
tions reported implementation of a structured manage-
ment plan. The treatment phase ranged from 6 to 16
weeks and included weekly [33, 34, 36–40] or bi-weekly
[35] review meetings between the care co-ordinator and
psychiatrist to monitor patient progress and make treat-
ment adjustments as required. Seven studies incorporated
a stepped care protocol [36, 40] and/or documented
criteria for dose escalation and/or psychiatry consultation.
[31, 33–35, 37] Of the five studies reporting follow-up
post the initial treatment phase, management varied from
3 to 4months [33, 36] to 8–12months [37, 38, 40] with
non-responders being offered additional psychological
treatment booster sessions. [33, 36, 37, 40] Table 2 out-
lines intervention management plans.
Scheduled patient follow-ups
While the majority of interventions included weekly or
fortnightly face to face follow up during the treatment
phase, one study relied on 3 telephone calls over 12
weeks to supplement automated symptom monitoring
[39] and a second study included 2 weekly telephone
calls and monthly face to face follow up. [34] The main-
tenance phase ranged from 3 to 12months with monthly
follow up, [31, 34–37, 40] although one study linked
follow up to regular (unspecified) oncology clinic visits.
[37] The web-based symptom monitoring study did not
include any maintenance or relapse prevention strategies
after the initial treatment period, although symptoms
continued to be monitored online. [34] Follow up proto-
cols are listed in Table 2.
Enhanced inter-professional communication
Across all studies communication was facilitated by the
care co-ordinator and there were clear communication pro-
tocols between the care co-ordinator and the supervisory
psychiatrist/psychologist regarding treatment review and
follow up. However, there was limited inter-professional
collaboration to establish the treatment plan and discuss
progress incorporated into any of the collaborative care
intervention models. For the three SMART studies, where
the GP was responsible for prescribing anti-depressants,
the care co-ordinator sent detailed written reports outlining
depression scores, progress and any treatment recommen-
dations to each GP. Although these studies did not detail
any formal communication with oncologists, copies of
reports were forwarded to other relevant professionals. [33,
36, 40]. Similarly, for studies where the oncologist was re-
sponsible for anti-depressant prescribing, the protocols in-
cluded feedback from the care co-ordinator to the
oncologist, [35, 39] although the nature of this feedback
was only documented in one study. [37] For two studies
the inter-professional communication plan was not speci-
fied. [34, 38] Across studies, engagement with the psych-
iatrist was typically limited to their review of the reports,
with recommendations subsequently communicated by the
care co-ordinator, although in one study the psychiatrist
was available to provide same day treatment decision sup-
port on an ad-hoc basis. [35] Case conferencing with the
non-mental health care providers was not a feature in any
of the collaborative care models described. Communication
protocols are listed in Table 3.
Quality of study reporting
Risk of bias was assessed based on Cochrane criteria.
(Additional file 3: Table S3). Randomisation processes
were well described in six studies. [33, 35–38, 40]. Across
studies patients and the health professionals delivering
care were not blinded to group allocation, however re-
searchers assessing outcomes remained blinded. Sample
size considerations were reported for four studies [33, 36,
39, 40] and met by three studies. [36, 39, 40] Rates of attri-
tion at the end of the initial treatment phase (3–4months)
were reported for three studies [33, 35, 36] and ranged
from 2 to 20%. Attrition during the maintenance phase
(6–9months) was reported for five studies [33, 34, 37–39]
and ranged from 4 to 57%. Long term attrition rates ≥12
months was reported for 4 studies (9–45%) [37–40].
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Analysis was based on intention to treat for seven studies.
[33–36, 38–40]
Discussion
Collaborative care interventions have the potential to
improve management of depression for people with can-
cer. However, before wider implementation, there are
several important questions that need to be addressed,
including clearer definition of the elements of collabora-
tive care (including roles, communication processes,
governance), which collaborative care components are
essential to treatment outcomes and who is best placed
to deliver care. We sought to explore these questions by
systematically describing the components of depression
collaborative care interventions. Eight collaborative care
RCTs were identified in this review. Five interventions
were developed specifically for patients with cancer and
three interventions were adapted from a more general
collaborative care intervention for management of de-
pression in older patients.
All studies identified in our review highlighted the
benefit of systematic, intensive depression treatment and
ongoing symptom monitoring, and reported decreased
depression symptoms in comparison to usual care. How-
ever, in contrast to collaborative care interventions more
generally, the review found the interventions were
primarily delivered in the hospital setting rather than in
primary care. While the hospital-based care model
makes sense for those receiving ongoing cancer treat-
ment, this model does little to address the preference of
patients for care closer to their home and issues of
access, particularly for those patients not in active treat-
ment. [43] Similarly, the continued dependence on hos-
pital specialists for the management of patients does not
ameliorate the scarcity of psycho-oncology resources
available in many cancer services.
In the literature, collaborative care is used to describe a
range of interventions of varying intensity from simple in-
terventions to encourage compliance with medication (typ-
ically delivered via telephone) to complex multi-component
interventions that incorporate psychological and pharma-
cological treatments and intensive monitoring and follow
up. [29] The studies identified in this review were consist-
ent with this heterogenous depiction of collaborative care,
ranging from symptom monitoring and patient navigation,
anti-depressant adherence models to interventions involv-
ing proactive follow-up by care co-ordinators working
closely with psychiatrists integrating pharmacological med-
ical and psychological treatments as part of individualized
treatment plans. As a result, treatment dose within the in-
terventions identified varied in level of intensity as well as
whether patients were able to access psychological and
pharmacological treatment. Importantly, a number of col-
laborative care models were reliant on anti-depressant
medication as the primary treatment. This is of concern
given current gold standard depression treatment recog-
nises the importance of combined cognitive behavioural
therapy and anti-depressant medication, [44] and the fact
that patients may be reluctant to take antidepressant medi-
cation. [45] Despite this, all studies documented clear path-
ways to patient management and follow up protocols to
ensure patients had access to appropriate levels of care.
Despite the focus of hospital-based care, the single
study in our review that provided care in the primary
care setting, [38] demonstrated the acceptability among
people diagnosed with cancer to attend primary care
appointments for depression management. Other studies
such as the Sharpe study [40] purported to provide the
option for patients to choose depression care in either
the cancer centre or primary care, however in truth this
was limited to anti-depressant prescribing rather than
overall psychological treatment and care coordination,
and the authors did not evaluate differences in outcome
based on whether GPs or oncologists were responsible
for anti-depressant management. Lack of GP engage-
ment across studies is surprising given the increasing
evidence GPs can play an important role in collaborative
care models in terms of continuity of care and reduced
patient burden due to excessive travel. From a health
service perspective, inclusion of GPs will in part address
some of the psycho-oncology workforce shortages that
mean that many patients do not receive depression
treatment in a timely manner. Under this model of care,
less complex patients’ pharmacological treatment can be
managed in the community, with psychiatry treating
only those patients with persistent symptoms.
A key feature of collaborative care models is a
team-based approach to delivery of care. Previous reviews
have highlighted the importance of a multi-disciplinary
approach to care, with inclusion of case managers with
mental health training reported to increase the efficacy of
the model. [29] Our review found in the context of cancer,
care co-ordination was primarily undertaken by nurses
trained to deliver the intervention. However, given their
limited specialist mental health training and consistent
with the findings of previous work conducted by our
Group that nurses are inadequately equipped to deliver
depression care, [46] there was a high level of psychiatry
case management incorporated into all studies, with psy-
chiatrists providing both staff supervision and treatment
decision-making. The time commitment required for on-
going psychiatry oversight limits long term sustainability
of the proposed model in routine care as it is predicated
on sufficient psychiatry staff to provide the high level of
supervision. Modifications of the model to include other
(non-medical) mental health staff such as clinical psychol-
ogists, such as demonstrated in the study by Steel [34] in
the delivery of psychological treatment and supervision of
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care co-ordinators in a stepped care model, with psychi-
atric review reserved for those patients in need of more
intensive psychiatric care, is one way to reduce is one way
to reduce the need for routine psychiatry oversight.
Additionally, over-reliance on specialist psychiatrist
involvement for treatment decision-making further un-
derscores the perception among oncology clinicians
that the mental wellbeing of patients is not the respon-
sibility of the cancer team and is further reinforced
when oncologists are informed of their patient’s depres-
sion diagnosis but not engaged in any delivery of
depression care. Similarly, although primary care physi-
cians provided pharmacological treatment to their
patients as part of the intervention, we were unable to
identify any studies that incorporated specific training
for GPs about prescribing and follow up. Upskilling of
non-mental health providers in evidence-based man-
agement of depression is essential for a truly collabora-
tive model to be sustainable. However, in the studies
identified in this review, communication pathways be-
tween hospital-based care providers and GPs failed to
engage GPs in shared decision-making as much of the
communication was via written reports or telephone
calls initiated by the care co-ordinator (nurse). This re-
sulted in passive engagement with treatment decision-
making whereby GPs implemented recommendations
for individual patients rather than establishing ongoing
communication where treatment decisions were jointly
shared between care providers, taking into account not
only the patient’s cancer and current depression
episode, but each patient’s wider medical and social his-
tory available from their primary care provider. Atten-
tion to clinical governance and management of shared
care is necessary to achieving positive patient out-
comes. The funding models and organisation of pri-
mary care and specialist care vary internationally and
influence the governance of such models. This context
necessitates closer examination of the processes and in-
gredients of findings regarding collaborative care when
evaluating transferability to diverse settings. Evidence
from “shared care” for primary mental disorders indi-
cates that substantial cross-organisational commitment
is required, with consistently delivered interventions,
and with close attention to staff selection, training and
supervision. [47] Implementation and longterm sustain-
ability of shared care models is contingent on funding
models that support clinical pathways that incorporate
primary and tertiary care, the introduction of informa-
tion technology to facilitate information sharing, and
collaborative interdisciplinary practice models.
Study limitations
The results of this review need to be considered in light
of a number of limitations. Firstly, we were unable to
conduct the planned meta-analysis to compare between
intervention components due to the small number of
studies identified. The review however does extend the
recent meta-analysis conducted by Li and colleagues
[30] that demonstrated overall efficacy of the model, as
we were able to qualitatively explore the components of
each intervention and compare the roles of health pro-
fessionals across interventions. Our analysis of inter-
vention components was however limited by the
intervention descriptions detailed in study publications;
the authors may have used a more detailed intervention
protocol when conducting their study and explicit ref-
erences to previously published standardised protocols
were included in assessment of interventions. Similarly,
we were unable to determine the quality of training
provided as part of the interventions or assess the qual-
ity of care provided by each member of the care team.
Generalisability of review results are also limited to in-
terventions published in English. All studies identified
also excluded patients with co-morbid psychiatric and
substance use disorders, limiting generalisability of the
study results given the high prevalence of co-occurring
mental health conditions in the general population.
Despite these limitations, this review highlights that,
collaborative care interventions for depression in oncol-
ogy do vary according to key criteria such as level of
inter-professional engagement and communication, in-
clusion of psychological and pharmacological treatment
options and documented follow up.
Conclusions
In the context of research, collaborative care interventions
for the management of depression in cancer have demon-
strated efficacy over usual care. However, the sustainability
of the level of hospital staff engagement raises questions
about the model’s utility in routine care. Current models of
care reflect hospital-based multi-disciplinary models of
care. Greater engagement with oncology and primary care
is required to reduce the over-reliance on specialist psych-
iatry services. Models that utilise existing community-based
services, including clinical psychologists in partnership with
GPs have the potential to enhance depression care. Given
the aim of collaborative models is to provide more care in
the community, future models need to consider the training
needs of primary care providers and there needs to be
greater emphasis placed on inter-professional communica-
tion and shared decision-making.
Future research is required to explore patient and pro-
vider acceptability as well as pragmatic non-inferiority
trial designs that incorporate process evaluations to
identify implementation strategies and practice change
required to move these models of care from research
into clinical practice.
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